It was demonstrated that FGFR4 Arg388 was not involved in tumour initiation, as the FGFR4 alleles showed a similar distribution in breast cancer patients and healthy controls and appeared in approximately 50% of the human population. Here, FGFR4 is linked to breast carcinoma.